Masimo (NASDAQ:MASI) turned in a fantastic performance in 2019, with its shares soaring 47%. The stock is also doing quite well so far in 2020, with shares up 15%.
This solid momentum shouldn't be derailed by Masimo's latest quarterly results. The medical technology company announced its 2019 fourth-quarter and full-year numbers after the market closed on Wednesday. Here are the highlights from Masimo's Q4 update.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,